UNSPSC 51422310: Fluprednisolone

This classification denotes a therapeutic glucocorticoid with the molecular formula C21H27FO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9H05937G3X, chemically known as pregna-1,4-diene-3,20-dione, 6-fluoro-11,17,21-trihydroxy-, (6.alpha.,11.beta.)- but generally known as fluprednisolone, which bears US NIH Compound Identifier 3390. European Medicines Agency schedules Fluprednisolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07736MIG.

UNSPSC 51422310 Fluprednisolone is a Commodity code that in recent state and local procurement activity maps to a much broader range of pharmaceutical products and pharmacy-related services than the code name alone suggests. State and local governments are using this code to solicit naloxone, drug deactivation systems, and pharmacy benefit management capabilities including direct-to-manufacturer prescription programs — indicating that the code functions as a catch-all pharmaceutical procurement vehicle rather than a narrow corticosteroid specification. Issuing bodies include county health departments and state health and human services agencies. Seminole County, Florida issued a competitive IFB for naloxone and safe drug deactivation systems in support of community health initiatives, while the Texas Health and Human Services Commission issued a Request for Information to explore direct-to-manufacturer prescription program capabilities — two distinct pharmaceutical supply and service categories under the same code.

Recent activity centers in Florida and Texas. Seminole County's IFB for naloxone and drug deactivation systems (1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries to Sanford, Florida, response due July 26, 2023) and the Texas HHS Commission's RFI for therapeutic pharmacy initiative capabilities (posted April 3, 2026, with the same-day response deadline) represent the scope of current state and local purchasing under this code. The mismatch between the code name and the actual solicitations suggests that state procurement offices are applying UNSPSC 51422310 inconsistently across pharmaceutical products and services; vendors pursuing opportunities under this code should anticipate wide variation in what is actually being bought and monitor both direct health department solicitations and state health agency RFIs for market intelligence.